Global private equity and venture capital news and research

Posts Tagged ‘Lumira Capital’

1 July 2014

Venture firms back $34m Series D for anti-heart failure device maker DC Devices

heart monitor medical healthcare A trio of venture capital firms have taken part in a $34m Series D funding round for DC Devices, which makes equipment designed to help treat heart failure.

17 April 2014

Lumira Capital co-leads $20m round for medtech business Cardiac Dimensions

news_heartmonitor.lrg Lumira Capital has co-led a $20m financing round for heart condition treatment business Cardiac Dimensions.

13 November 2013

Lumira Capital wins $10m LP commitment under Canada’s Venture Capital Action Plan

vancouver-canada_sq North American healthcare and life sciences venture capital firm Lumira Capital has sealed a $10m commitment for its second fund from the Government of Canada’s Venture Capital Action Plan initiative.

28 March 2013

CVCA, Canadian venture firms attack plan to scrap LSVCC tax credits $

canadian flag 5_sq Plans to wipe out tax credits for investments in Canadian SMEs have been attacked by the country's venture industry for creating a "severe risk" of constricting the supply of early-stage capital.

18 February 2013

Sante Ventures leads $27.3m round for medical device developer BAROnova

BAROnova has boosted its coffers with a $27.3m Series C fundraising, led by Sante Ventures and Boston Scientific Corporation.

26 October 2012

GlaxoSmithKline VC arm leads $35m Thrasos Therapeutics round

Thrasos Therapeutics kidney - AltAssets Private Equity News The corporate venture arm of pharmaceutical giant GlaxoSmithKline has led a $35m financing round for kidney injury treatment company Thrasos Therapeutics.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015